- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3-mediated Inflammation in CardioOncology: Sterile yet Harmful
Authors
Keywords
-
Journal
Translational Research
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-08-07
DOI
10.1016/j.trsl.2022.08.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Interleukin 18-Dependent Immune Responses Are Associated With Myopericarditis After COVID-19 mRNA Vaccination
- (2022) Taejoon Won et al. Frontiers in Immunology
- Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer
- (2022) Anja Karlstaedt et al. Nature Reviews Cardiology
- The Role of Anthracyclines in Cardio-Oncology: Oxidative Stress, Inflammation, and Autophagy
- (2022) Leonardo Schirone et al. Oxidative Medicine and Cellular Longevity
- Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway
- (2022) Hui Zhang et al. Journal of Inflammation Research
- Mitochondrial Dynamics in Adult Cardiomyocytes and Heart Diseases
- (2021) Anqi Li et al. Frontiers in Cell and Developmental Biology
- mRNA vaccine for cancer immunotherapy
- (2021) Lei Miao et al. Molecular Cancer
- Resveratrol reduces cardiac NLRP3‐inflammasome activation and systemic inflammation to lessen doxorubicin‐induced cardiotoxicity in juvenile mice
- (2021) Zaid H. Maayah et al. FEBS LETTERS
- Effect of Colchicine on Myocardial Injury in Acute Myocardial Infarction
- (2021) Nathan Mewton et al. CIRCULATION
- Autophagy in major human diseases
- (2021) Daniel J Klionsky et al. EMBO JOURNAL
- Immune checkpoint inhibitors and cardiotoxicity: possible mechanisms, manifestations, diagnosis and management
- (2021) Seyed Parsa Eftekhar et al. Expert Review of Anticancer Therapy
- The SGLT-2 inhibitor dapagliflozin reduces cell death and apoptosis in cardiomyocytes exposed to trastuzumab and doxorubicin through NLRP3-mediated pathways.
- (2021) Nicola Maurea et al. JOURNAL OF CLINICAL ONCOLOGY
- Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression
- (2021) Vincenzo Quagliariello et al. Frontiers in Oncology
- Gamma Radiation Induce Inflammasome Signaling and Pyroptosis in Microvascular Endothelial Cells
- (2021) Alhaji Osman Smith et al. Journal of Inflammation Research
- An update on the pathophysiology of acute and recurrent pericarditis
- (2021) Aldo BONAVENTURA et al. PANMINERVA MEDICA
- Targeting the NLRP3 inflammasome in cardiovascular diseases
- (2021) Stefano Toldo et al. PHARMACOLOGY & THERAPEUTICS
- Late Ca2+Spark Arrhythmogenesis in Failing Cardiac Myocytes
- (2020) Ewan D. Fowler et al. BIOPHYSICAL JOURNAL
- Rho Kinase Inhibition by Fasudil Attenuates Adriamycin-Induced Chronic Heart Injury
- (2020) Yi Yan et al. Cardiovascular Toxicology
- Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a Position Statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
- (2020) Alexander R. Lyon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Precisely and Efficiently Enzyme Response Microspheres with Immune Removal Escape Loaded with MCC950 Ameliorate Cardiac Dysfunction in Acute Myocardial Infarction
- (2020) Panke Cheng et al. Journal of Biomedical Nanotechnology
- ACUTE EFFECTS OF INTERLEUKIN-1 BLOCKADE USING ANAKINRA IN PATIENTS WITH ACUTE PERICARDITIS
- (2020) George F. Wohlford et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mitochondrial and mitochondrial‐independent pathways of myocardial cell death during ischaemia and reperfusion injury
- (2020) Sean M. Davidson et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- THE SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR DAPAGLIFLOZIN EXERTS CARDIOPROTECTIVE EFFECTS AGAINST DOXORUBICIN AND TRASTUZUMAB TOXICITY THROUGH TLR4/MYD88/NF-KB SIGNALING AND NLRP3 INFLAMMASOME PATHWAY
- (2020) Nicola Maurea et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
- (2020) Joerg Herrmann Nature Reviews Cardiology
- The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury
- (2020) Shanshan Huang et al. Frontiers in Cell and Developmental Biology
- Involvement of ROS/NLRP3 Inflammasome Signaling Pathway in Doxorubicin-Induced Cardiotoxicity
- (2020) Shanshan Wei et al. Cardiovascular Toxicology
- The Role of Biomarkers in Cardio-Oncology
- (2020) Kajaluxy Ananthan et al. Journal of Cardiovascular Translational Research
- Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial
- (2020) David C. Tong et al. CIRCULATION
- Colchicine in Patients with Chronic Coronary Disease
- (2020) Stefan M. Nidorf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical Models
- (2020) Vincenzo Quagliariello et al. Journal of Personalized Medicine
- Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis
- (2020) Allan L. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
- (2020) Niklas Lonnemann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca 2+ /Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling
- (2019) Takeshi Suetomi et al. CIRCULATION
- Targeted Cancer Therapies With Pericardial Effusions Requiring Pericardiocentesis Focusing on Immune Checkpoint Inhibitors
- (2019) Nicolas Palaskas et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade
- (2019) Tinna Christersdottir et al. EUROPEAN HEART JOURNAL
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction
- (2019) Masafumi Takahashi JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- NLRP3 inflammasome in cardioprotective signaling
- (2019) Coert J Zuurbier JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- The NLRP3 inflammasome in acute myocardial infarction
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
- (2019) Ying Jin et al. Journal of the American Heart Association
- Drugs to Inhibit the NLRP3 Inflammasome
- (2019) Adolfo Gabriele Mauro et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition
- (2019) Lieselotte Vande Walle et al. PLOS BIOLOGY
- Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3
- (2019) Liping Meng et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
- (2019) Jean-Claude Tardif et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of Cardiorespiratory Fitness Following Thoracic Radiotherapy in Lung or Breast Cancer Survivors
- (2019) Justin M. Canada et al. AMERICAN JOURNAL OF CARDIOLOGY
- Aging Induces an Nlrp3 Inflammasome-Dependent Expansion of Adipose B Cells That Impairs Metabolic Homeostasis
- (2019) Christina D. Camell et al. Cell Metabolism
- Cardiovascular Toxicity Induced by Kinase Inhibitors: Mechanisms and Preclinical Approaches
- (2019) Sarah D. Lamore et al. CHEMICAL RESEARCH IN TOXICOLOGY
- The SGK1 inhibitor EMD638683, prevents Angiotensin II–induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation
- (2018) Wenqiang Gan et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
- (2018) Chunxia Yao et al. CIRCULATION
- NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
- (2018) Alena Grebe et al. CIRCULATION RESEARCH
- Anthracycline Cardiotoxicity
- (2018) Daniel Bernstein CIRCULATION RESEARCH
- Autoimmune Myocarditis Caused by Immune Checkpoint Inhibitors Treated With Antithymocyte Globulin
- (2018) Varun Jain et al. JOURNAL OF IMMUNOTHERAPY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
- (2018) Carlo Marchetti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immune checkpoint inhibitors and cardiovascular toxicity
- (2018) Alexander R Lyon et al. LANCET ONCOLOGY
- Cardiotoxicity of Cancer Therapies
- (2018) Pratik Mondal et al. Cardiology in Review
- Role of pyroptosis in cardiovascular disease
- (2018) Zeng Zhaolin et al. CELL PROLIFERATION
- Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab
- (2017) Milos Dokmanovic et al. Expert Opinion on Drug Metabolism & Toxicology
- Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
- (2017) Peter A Henriksen HEART
- Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production bothin vitroand in a mouse model of inflammation
- (2017) Mariela Castelblanco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasome and Autophagy Regulation: A Two-way Street
- (2017) Qian Sun et al. MOLECULAR MEDICINE
- The NLRP3 inflammasome in acute myocardial infarction
- (2017) Stefano Toldo et al. Nature Reviews Cardiology
- Adapting to obesity with adipose tissue inflammation
- (2017) Shannon M. Reilly et al. Nature Reviews Endocrinology
- Acute Myocardial Infarction
- (2017) Jeffrey L. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute Pericarditis
- (2017) Niraj S. Doctor et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway
- (2017) Takayuki Kimura et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction
- (2017) Luís E. Pavillard et al. Oncotarget
- Trastuzumab cardiotoxicity: from clinical trials to experimental studies
- (2016) Balazs T Nemeth et al. BRITISH JOURNAL OF PHARMACOLOGY
- HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins
- (2016) Damien Bertheloot et al. Cellular & Molecular Immunology
- Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence
- (2016) Antonio Brucato et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Preventing antiblastic drug-related cardiomyopathy
- (2016) Christian Cadeddu et al. Journal of Cardiovascular Medicine
- Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes
- (2016) Nishant Mohan et al. MOLECULAR CANCER THERAPEUTICS
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
- (2016) Xing Liu et al. NATURE
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer’s disease in rodent models
- (2016) Michael J. D. Daniels et al. Nature Communications
- NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity
- (2016) Motoi Kobayashi et al. Scientific Reports
- The Inflammasome in Myocardial Injury and Cardiac Remodeling
- (2015) Stefano Toldo et al. ANTIOXIDANTS & REDOX SIGNALING
- Anti-Inflammatory Treatment With Colchicine in Acute Myocardial InfarctionClinical Perspective
- (2015) Spyridon Deftereos et al. CIRCULATION
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Chemotherapy-induced cardiomyopathy
- (2015) Angela Y. Higgins et al. HEART FAILURE REVIEWS
- Pharmacologic Inhibition of the NLRP3 Inflammasome Preserves Cardiac Function After Ischemic and Nonischemic Injury in the Mouse
- (2015) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy
- (2015) Ya-Ping Chang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Unknown
- (2015) Eleonora Mezzaroma et al. MOLECULAR MEDICINE
- Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter
- (2015) Jing Wang et al. NATURE MEDICINE
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Hydrogen sulfide and cardioprotection — Mechanistic insights and clinical translatability
- (2015) Fadi N. Salloum PHARMACOLOGY & THERAPEUTICS
- Colchicine—Update on mechanisms of action and therapeutic uses
- (2015) Ying Ying Leung et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Targeting Conformational Plasticity of Protein Kinases
- (2014) Michael Tong et al. ACS Chemical Biology
- Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis
- (2014) Yan Wang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Acute Cardiotoxic Effects of Adjuvant Trastuzumab Treatment and Its Relation to Oxidative Stress
- (2014) Ahmet Dirican et al. ANGIOLOGY
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs
- (2014) John Wong et al. CANCER BIOLOGY & THERAPY
- Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart
- (2014) Stefano Toldo et al. CARDIOVASCULAR RESEARCH
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Letter by Mezzaroma, et al Regarding Article, “NLRP3 Inflammasome as a Therapeutic Target in Myocardial Infarction”
- (2014) Eleonora Mezzaroma et al. International Heart Journal
- NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
- (2014) Masafumi Takahashi International Heart Journal
- Formation of the inflammasome in acute myocarditis
- (2014) Stefano Toldo et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Evaluation and Management of Patients With Heart Disease and Cancer: Cardio-Oncology
- (2014) Joerg Herrmann et al. MAYO CLINIC PROCEEDINGS
- Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
- (2014) Yuya Yoshimoto et al. PLoS One
- Role of NLRP3 (cryopyrin) in acute myocardial infarction
- (2013) Eleonora Mezzaroma et al. CARDIOVASCULAR RESEARCH
- Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death
- (2013) Heriberto Lima Jr. et al. CELL CYCLE
- Mitochondrial Cardiolipin Is Required for Nlrp3 Inflammasome Activation
- (2013) Shankar S. Iyer et al. IMMUNITY
- A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia–Reperfusion in the Mouse
- (2013) Carlo Marchetti et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation
- (2013) M. E. Heid et al. JOURNAL OF IMMUNOLOGY
- Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice
- (2013) M. Khair ElZarrad et al. PLoS One
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Regulation of inflammasome signaling
- (2012) Vijay A K Rathinam et al. NATURE IMMUNOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Doxorubicin and daunorubicin induce processing and release of interleukin-1β through activation of the NLRP3 inflammasome
- (2011) Kristin A. D. Sauter et al. CANCER BIOLOGY & THERAPY
- Hydrogen sulfide protects H9c2 cells against doxorubicin-induced cardiotoxicity through inhibition of endoplasmic reticulum stress
- (2011) Xiu-Yu Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
- (2011) Bolormaa Vandanmagsar et al. NATURE MEDICINE
- The Sterile Inflammatory Response
- (2010) Kenneth L. Rock et al. Annual Review of Immunology
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease
- (2010) Y. Luan et al. EUROPACE
- Recombinant human interleukin-1 receptor antagonist protects mice against acute doxorubicin-induced cardiotoxicity
- (2010) Jinzhou Zhu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
- (2010) Christine Juliana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Somatic gene mutation and human disease other than cancer: An update
- (2010) Robert P. Erickson MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
- (2009) Mohamed Lamkanfi et al. JOURNAL OF CELL BIOLOGY
- Pyroptosis: host cell death and inflammation
- (2009) Tessa Bergsbaken et al. NATURE REVIEWS MICROBIOLOGY
- The Nuclear Factor NF- B Pathway in Inflammation
- (2009) T. Lawrence Cold Spring Harbor Perspectives in Biology
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent Pathways
- (2008) Leo I. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started